Despite the fact that UCB is easily accessible and associated with lower rates of graft versus host disease (GVHD), insufficient quantities of whole nucleated cells and CD34+ cell dosage forms in UCB units cause delayed hematopoietic healing and increased rates of graft failure, which tend to increase the infection rate. The gene discussed is CD34; the disease is graft versus host disease.